Medical comms - Press Releases

Date	Title	Company
07-Apr-2021	FDA Keynote Speakers at SMi's 4th Annual Pharmaceutical Microbiology East Coast Virtual Conference in 3 weeks	SMi Group
05-Apr-2021	Allergy Treatment Market Worth US$ 35,812.33 Mn by 2028 and to grow at a CAGR of 6.9%	theinsightpartners
01-Apr-2021	Drugs of Abuse Testing Market Report 2021-2031 : Newly Published By Visiongain	Visiongain Limited
01-Apr-2021	Medical Perfusion Technology Market by Technology Trends 2021 - XVIVO Perfusion, OrganOx Limited, TransMedics, Organ Recovery Systems, Xenios AG	theinsightpartners
29-Mar-2021	gaitQ Awarded Grant by the UK’s National Institute for Health Research for the continued development of its system	gaitQ
29-Mar-2021	EMA issues advice on the use of Celltrion’s anti-COVID-19 monoclonal antibody treatment regdanvimab (CT-P59) for COVID-19 patients in the European Union	Celltrion Group
29-Mar-2021	Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations	Autolus Therapeutics plc
29-Mar-2021	The PROTECT-V trial investigating UNIONs COVID-19 candidate receives Urgent Public Health Prioritization from the UK government	UNION therapeutics A/S
29-Mar-2021	HUTCHMED Initiates International Phase I Trials of IDH1/2 Dual Inhibitor in Patients with Advanced Solid Tumors or Hematological Malignancies	HUTCHMED
29-Mar-2021	OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer	OKYO Pharma Limited
29-Mar-2021	Instant Covid Tests London to launch first test centre using 20-second Virolens technology	Instant Covid Tests London (ICTL)
29-Mar-2021	Syncona cornerstones $148 million Series C Financing in Gyroscope	Syncona Ltd
29-Mar-2021	Vertex Receives Australian TGA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat People With Cystic Fibrosis Ages 12 Years and Older Who Have At Least One F508del Mutation	Vertex Pharmaceuticals Incorporated
29-Mar-2021	Gadopiclenol: positive results for Phase III clinical trials	Guerbet
29-Mar-2021	Avifavir obtains its first registration in Asia	Russian Direct Investment Fund
29-Mar-2021	PrecisionLife continues growth and expansion with acquisition of Danish genomic analytics innovator GenoKey	PrecisionLife
29-Mar-2021	HUTCHMED Initiates a Phase Ib/II Trial of Surufatinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors	Hutchison China MediTech Limited
29-Mar-2021	Molecular ‘cookie cutter’ technique could provide key for COVID drug discovery	University of Birmingham
29-Mar-2021	LEO Foundation and Nordic Capital partner up to further strengthen LEO Pharma’s leading position in medical dermatology	Nordic Capital
29-Mar-2021	Amzell BV appoints new Chairman and CEO as its portfolio of product development candidates approach Phase 3 trials	Amzell BV